3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
60
Neoplasms
58
Lung Neoplasms
32
Prostatic Neoplasms
24
Colorectal Neoplasms
24
Carcinoma, Non-Small-Cell Lung
21
Neoplastic Cells, Circulating
20
Head and Neck Neoplasms
19
Pancreatic Neoplasms
17
Melanoma
14
Ovarian Neoplasms
13
Carcinoma, Hepatocellular
12
Esophageal Neoplasms
10
Colonic Neoplasms
10
Uterine Cervical Neoplasms
9
Liver Neoplasms
9
Glioma
9
Squamous Cell Carcinoma of Head and Neck
8
Multiple Myeloma
8
Leukemia, Myeloid, Acute
8
Sarcoma
7
Neoplasm Metastasis
7
Endometrial Neoplasms
7
Stomach Neoplasms
6
Neoplasm, Residual
6
Myeloproliferative Disorders
6
Leukemia
6
Kidney Neoplasms
6
Gastrointestinal Neoplasms
6
Carcinoma, Renal Cell
6
Interventions
X-Rays
1
Tomography, X-Ray Computed
1
Symptom Assessment
1
Sulfonylurea Compounds
1
Sodium-Glucose Transporter 2 Inhibitors
1
Palliative Care
1
Exercise
1
Electrocardiography
1
Drug Delivery Systems
1
Dipeptidyl-Peptidase IV Inhibitors
1
Bronchoscopy
1
Bronchoalveolar Lavage
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Pulmonary Disease, Chronic Obstructive
×
Blood Specimen Collection
×
Clear all
NCT06122077
2025-08-05
PROACT-LUNG
Freenome Holdings Inc.
Recruiting
20,000 enrolled